共 50 条
- [1] Association between symptoms in irritable bowel syndrome with diarrhea (IBS-D): A pooled correlation and tricomposite endpoint analysis of two phase 3, randomized, placebo-controlled, rifaximin trialsNEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35Staller, K.Lacy, B. E.Sayuk, G. S.Rao, S. S. C.Karsan, H. A.Neshatiana, L.Lunsford, T. N.Allen, C.Heimanson, Z.Brenner, D. M.
- [2] Rifaximin Improves Both Fecal Urgency and Stool Consistency in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D): A Composite Endpoint Analysis of Two Randomized, Phase 3 TrialsAMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S384 - S385Cash, Brooks D.Staller, KyleNeshatian, LeilaAllen, ChristopherHeimanson, ZeevRezaie, Ali
- [3] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 TrialsAMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254Pimentel, MarkCash, Brooks D.Wolf, RayLembo, Anthony J.
- [4] EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALSGASTROENTEROLOGY, 2018, 154 (06) : S498 - S499Lacy, Brian E.Pimentel, MarkChang, ChristopherHeimanson, ZeevLembo, Anthony J.
- [5] A POOLED ANALYSIS OF TWO PHASE 3, PLACEBO-CONTROLLED STUDIES ASSESSING THE IMPACT OF COLONOSCOPY TIMING ON RIFAXIMIN EFFICACY IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D)GASTROENTEROLOGY, 2020, 158 (06) : S855 - S856Chang, ChristopherChey, William D.Pimentel, MarkHeimanson, ZeevLacy, Brian E.
- [6] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONSGASTROENTEROLOGY, 2018, 154 (06) : S499 - S499Lembo, Anthony J.Rao, Satish S.Rezaie, AliHeimanson, ZeevPimentel, Mark
- [7] Assessing the Efficacy of Rifaximin in Diarrhea-Predominant Irritable Syndrome (IBS-D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo-Controlled TrialsAMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S254 - S254Pimentel, MarkCash, Brooks D.Lacy, Brian E.Heimanson, ZeevLembo, Anthony J.
- [8] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With RifaximinAMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236Lembo, Anthony J.Heimanson, ZeevPimentel, Mark
- [9] Plecanatide simultaneously improves multiple symptoms of irritable bowel syndrome with constipation (IBS-C): A unique composite endpoint analysis of randomized, phase 3 trialsNEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35Sayuk, G. S.Laitman, A. P.Allen, C.Schoenfeld, P. S.
- [10] RIFAXIMIN IMPROVES BOTH ABDOMINAL PAIN AND BLOATING IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A COMPOSITE ENDPOINT ANALYSIS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALSGASTROENTEROLOGY, 2021, 160 (06) : S281 - S281Lacy, Brian E.Chang, LinRao, Satish S.Heimanson, ZeevSayuk, Gregory S.